Crispr Therapeutics shares owned by Mayflower Financial Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mayflower Financial Advisors
from 13F filings
Historical chart of Mayflower Financial Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Mayflower Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Mayflower Financial Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $80k | 13k | 5.96 |
| 2023-12-31 | $25k | 13k | 2.02 |
| 2023-09-30 | $22k | 13k | 1.71 |
| 2023-06-30 | $24k | 13k | 1.91 |
| 2023-03-31 | $22k | 13k | 1.73 |
| 2022-12-31 | $22k | 13k | 1.77 |
| 2022-09-30 | $29k | 13k | 2.30 |
| 2022-06-30 | $28k | 13k | 2.22 |
| 2022-03-31 | $50k | 13k | 3.85 |
More positions owned by Mayflower Financial Advisors
View all positions for Mayflower Financial Advisors